Pharmacogenomic testing for antidepressants could help reduce the time and cost it takes to find the most effective medication for a patient, according to a new study. Scientists developed a ...

A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating trial-and-error process.

LAS VEGAS -- Families who received the results of pharmacogenomic testing for their children at one center understood the results they received but didn't often share the test results with other ...

Pharmacogenomic testing, a mature and growing aspect of personalized medicine, has demonstrated significant ability to enhance health outcomes and reduce healthcare costs. Since the 1970s, ...

Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy ...

Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...

A U.S. Department of Veterans Affairs study has found that pharmacogenomic testing can help clinicians avoid prescribing antidepressant medications that may have undesirable outcomes. Results from the ...

CLEVELAND — Imagine if you could know if that medication your doctor is about to prescribe would even work for you. The technology is real. It's called pharmacogenomics, and some hope it becomes part ...

A large-scale clinical trial conducted within the Department of Veterans Affairs indicates that analyzing a patient’s genetic makeup can assist medical providers in avoiding antidepressants that may ...

A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient ...

"The most striking finding was the realization that the test wasn't useful most of the time. This is seen in the control condition in which about 20% of patients were started on a medication with a ...

Rosalind Brown had blood clots in her lungs. For years, her doctors tried to get the dose of a blood thinner just right to prevent the risk of a heart attack or other life-threatening complications ...